Showing results (1-10 of 138) with videos related to

Sort By:
Pageof 14
Journal of Personalized Medicine|October 27, 2022
Personalized Medicine: PharmacokineticsYoussef Daali
Toxicology and Applied Pharmacology|April 24, 2016
An extensive cocktail approach for rapid risk assessment of in vitro CYP450 direct reversible inhibition by xenobiotic exposureDany Spaggiari, Youssef Daali, Serge Rudaz
Basic & Clinical Pharmacology & Toxicology|September 8, 2018
Genotype-sensitive reversible and time-dependent CYP2D6 inhibition in human liver microsomesFlavia Storelli, Jules Desmeules, Youssef Daali
Journal of Pharmaceutical Policy and Practice|December 10, 2025
The use of internet for health information by hospitalised patients in Switzerland and Qatar: a comparative cross-sectional studyAmeena Jesaimani, Jassim Fakhro, Youssef Daali
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2019
Physiologically-Based Pharmacokinetic Modeling for the Prediction of CYP2D6-Mediated Gene-Drug-Drug InteractionsFlavia Storelli, Jules Desmeules, Youssef Daali
Basic & Clinical Pharmacology & Toxicology|June 6, 2009
Uptake/efflux transport of tramadol enantiomers and O-desmethyl-tramadol: focus on P-glycoproteinMouna Kanaan, Youssef Daali, Pierre Dayer, et al.
Analytical and Bioanalytical Chemistry|June 5, 2014
Phenotyping of CYP450 in human liver microsomes using the cocktail approachDany Spaggiari, Laurent Geiser, Youssef Daali, et al.
Clinical Pharmacokinetics|May 28, 2019
Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological ApproachesGaëlle Magliocco, Aurélien Thomas, Jules Desmeules, et al.
Basic & Clinical Pharmacology & Toxicology|November 24, 2020
The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 in vitroValeria Cagno, Gaelle Magliocco, Caroline Tapparel, et al.
Pageof 14